Cancer Home > Bladder Cancer Statistics
Bladder Cancer Statistics on Survival
Survival rates can be calculated by different methods for different purposes. The survival rates presented here are based on the relative survival rate. The relative survival rate measures the survival of people with bladder cancer in comparison to the general population to estimate the effect of the disease.
The overall five-year relative bladder cancer survival rate from 1995 to 2001 was 81.8 percent. The five-year relative survival rates by race and sex were:
- 84.3 percent for Caucasian men
- 78.6 percent for Caucasian women
- 69.7 percent for African American men
- 53.9 percent for African American women.
Statistics on Bladder Cancer StagesThe stage of disease plays a role in a person's bladder cancer prognosis. Based on historical data:
- Seventy-five percent of urinary bladder cancer cases are diagnosed while the cancer is still confined to the primary site (localized stage)
- Nineteen percent of urinary bladder cancer cases are diagnosed after the cancer has spread to regional lymph nodes or directly beyond the primary site
- Three percent of urinary bladder cancer cases are diagnosed after the cancer has already metastasized (distant stage)
- Three percent of urinary bladder cancer cases had staging information that was unknown.
The corresponding five-year relative survival rates were:
- 94.2 percent for localized
- 48.4 percent for regional
- 6.2 percent for distant
- 61.1 percent for unstaged.
What Is a Person's Lifetime Risk for Bladder Cancer?
Based on rates from 2000 to 2002, 2.28 percent of men and women (or 1 in 44 men and women) born today will be diagnosed with bladder cancer at some point during their lifetime. These statistics are called the lifetime risk of developing bladder cancer.
Sometimes, it is more useful to look at the probability of developing bladder cancer between two age groups. For example, 1.19 percent of men will develop the disease between their 50th and 70th birthdays, compared to 0.33 percent of women.